Materias dentro de su búsqueda.
Mostrando 2,661 - 2,680 Resultados de 4,314 Para Buscar '"TED"', tiempo de consulta: 0.47s Limitar resultados
  1. 2661
    “…BACKGROUND: Thyroid eye disease (TED) is the most common autoimmune disease and usually occurs in patients with hyperthyroidism. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A data-driven approach for the discovery of biomarkers associated with thyroid eye disease
  2. 2662
    “…BACKGROUND: Dysthyroid optic neuropathy (DON) is one of the most serious vision-threatening complications of thyroid eye disease (TED); however, accurate and established diagnostic tools for DON are yet lacking. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Combination Model of Thyrotrophin Receptor Antibody and Volumetric Orbital Apex Crowding Index as an Indicator of Dysthyroid Optic Neuropathy
  3. 2663
    “…Thyroid eye disease (TED) is a vision-threatening and debilitating condition that until very recently had no Food and Drug Administration (FDA)-approved medical therapies. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Teprotumumab in Clinical Practice: Recommendations and Considerations From the OPTIC Trial Investigators
  4. 2664
    “…OBJECTIVES: The clinical course of thyroid eye disease (TED) is heterogeneous and predicting patients who may develop the severe sequelae of the disease is difficult. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Longitudinal association of thyroid-stimulating immunoglobulin levels with clinical characteristics in thyroid eye disease
  5. 2665
    “…Data will be collected from the TED bracelet and then compared to a paper-based fall diary. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    The prevention of falls in patients with Parkinson’s disease with in-home monitoring using a wearable system: a pilot study protocol
  6. 2666
    por Haagsma, Juanita A, James, Spencer L, Castle, Chris D, Dingels, Zachary V, Fox, Jack T, Hamilton, Erin B, Liu, Zichen, Lucchesi, Lydia R, Roberts, Nicholas L S, Sylte, Dillon O, Adebayo, Oladimeji M, Ahmadi, Alireza, Ahmed, Muktar Beshir, Aichour, Miloud Taki Eddine, Alahdab, Fares, Alghnam, Suliman A, Aljunid, Syed Mohamed, Al-Raddadi, Rajaa M, Alsharif, Ubai, Altirkawi, Khalid, Anjomshoa, Mina, Antonio, Carl Abelardo T, Appiah, Seth Christopher Yaw, Aremu, Olatunde, Arora, Amit, Asayesh, Hamid, Assadi, Reza, Awasthi, Ashish, Ayala Quintanilla, Beatriz Paulina, Balalla, Shivanthi, Banstola, Amrit, Barker-Collo, Suzanne Lyn, Bärnighausen, Till Winfried, Bazargan-Hejazi, Shahrzad, Bedi, Neeraj, Behzadifar, Masoud, Behzadifar, Meysam, Benjet, Corina, Bennett, Derrick A, Bensenor, Isabela M, Bhaumik, Soumyadeep, Bhutta, Zulfiqar A, Bijani, Ali, Borges, Guilherme, Borschmann, Rohan, Bose, Dipan, Boufous, Soufiane, Brazinova, Alexandra, Campuzano Rincon, Julio Cesar, Cárdenas, Rosario, Carrero, Juan J, Carvalho, Félix, Castañeda-Orjuela, Carlos A, Catalá-López, Ferrán, Choi, Jee-Young J, Christopher, Devasahayam J, Crowe, Christopher Stephen, Dalal, Koustuv, Daryani, Ahmad, Davitoiu, Dragos Virgil, Degenhardt, Louisa, De Leo, Diego, De Neve, Jan-Walter, Deribe, Kebede, Dessie, Getenet Ayalew, deVeber, Gabrielle Aline, Dharmaratne, Samath Dhamminda, Doan, Linh Phuong, Dolan, Kate A, Driscoll, Tim Robert, Dubey, Manisha, El-Khatib, Ziad, Ellingsen, Christian Lycke, El Sayed Zaki, Maysaa, Endries, Aman Yesuf, Eskandarieh, Sharareh, Faro, Andre, Fereshtehnejad, Seyed-Mohammad, Fernandes, Eduarda, Filip, Irina, Fischer, Florian, Franklin, Richard Charles, Fukumoto, Takeshi, Gezae, Kebede Embaye, Gill, Tiffany K, Goulart, Alessandra C, Grada, Ayman, Guo, Yuming, Gupta, Rahul, Haghparast Bidgoli, Hassan, Haj-Mirzaian, Arvin, Haj-Mirzaian, Arya, Hamadeh, Randah R, Hamidi, Samer, Haro, Josep Maria, Hassankhani, Hadi, Hassen, Hamid Yimam, Havmoeller, Rasmus, Hendrie, Delia, Henok, Andualem, Híjar, Martha, Hole, Michael K, Homaie Rad, Enayatollah, Hossain, Naznin, Hostiuc, Sorin, Hu, Guoqing, Igumbor, Ehimario U, Ilesanmi, Olayinka Stephen, Irvani, Seyed Sina Naghibi, Islam, Sheikh Mohammed Shariful, Ivers, Rebecca Q, Jacobsen, Kathryn H, Jahanmehr, Nader, Jakovljevic, Mihajlo, Jayatilleke, Achala Upendra, Jha, Ravi Prakash, Jonas, Jost B, Jorjoran Shushtari, Zahra, Jozwiak, Jacek Jerzy, Jürisson, Mikk, Kabir, Ali, Kalani, Rizwan, Kasaeian, Amir, Kelbore, Abraham Getachew, Kengne, Andre Pascal, Khader, Yousef Saleh, Khafaie, Morteza Abdullatif, Khalid, Nauman, Khan, Ejaz Ahmad, Khoja, Abdullah T, Kiadaliri, Aliasghar A, Kim, Young-Eun, Kim, Daniel, Kisa, Adnan, Koyanagi, Ai, Kuate Defo, Barthelemy, Kucuk Bicer, Burcu, Kumar, Manasi, Lalloo, Ratilal, Lam, Hilton, Lami, Faris Hasan, Lansingh, Van C, Leasher, Janet L, Li, Shanshan, Linn, Shai, Lunevicius, Raimundas, Machado, Flavia R, Magdy Abd El Razek, Hassan, Magdy Abd El Razek, Muhammed, Mahotra, Narayan Bahadur, Majdan, Marek, Majeed, Azeem, Malekzadeh, Reza, Malik, Manzoor Ahmad, Malta, Deborah Carvalho, Manda, Ana-Laura, Mansournia, Mohammad Ali, Massenburg, Benjamin Ballard, Maulik, Pallab K, Meheretu, Hailemariam Abiy Alemu, Mehndiratta, Man Mohan, Melese, Addisu, Mendoza, Walter, Mengesha, Melkamu Merid, Meretoja, Tuomo J, Meretoja, Atte, Mestrovic, Tomislav, Miazgowski, Tomasz, Miller, Ted R, Mini, GK, Mirrakhimov, Erkin M, Moazen, Babak, Mohammad Gholi Mezerji, Naser, Mohammadibakhsh, Roghayeh, Mohammed, Shafiu, Molokhia, Mariam, Monasta, Lorenzo, Mondello, Stefania, Montero-Zamora, Pablo A, Moodley, Yoshan, Moosazadeh, Mahmood, Moradi, Ghobad, Moradi-Lakeh, Maziar, Morawska, Lidia, Velásquez, Ilais Moreno, Morrison, Shane Douglas, Moschos, Marilita M, Mousavi, Seyyed Meysam, Murthy, Srinivas, Musa, Kamarul Imran, Naik, Gurudatta, Najafi, Farid, Nangia, Vinay, Nascimento, Bruno Ramos, Ndwandwe, Duduzile Edith, Negoi, Ionut, Nguyen, Trang Huyen, Nguyen, Son Hoang, Nguyen, Long Hoang, Nguyen, Huong Lan Thi, Ningrum, Dina Nur Anggraini, Nirayo, Yirga Legesse, Ofori-Asenso, Richard, Ogbo, Felix Akpojene, Oh, In-Hwan, Oladimeji, Olanrewaju, Olagunju, Andrew T, Olagunju, Tinuke O, Olivares, Pedro R, Orpana, Heather M, Otstavnov, Stanislav S, P A, Mahesh, Pakhale, Smita, Park, Eun-Kee, Patton, George C, Pesudovs, Konrad, Phillips, Michael R, Polinder, Suzanne, Prakash, Swayam, Radfar, Amir, Rafay, Anwar, Rafiei, Alireza, Rahimi, Siavash, Rahimi-Movaghar, Vafa, Rahman, Muhammad Aziz, Rai, Rajesh Kumar, Ramezanzadeh, Kiana, Rawaf, Salman, Rawaf, David Laith, Renzaho, Andre M N, Resnikoff, Serge, Rezaeian, Shahab, Roever, Leonardo, Ronfani, Luca, Roshandel, Gholamreza, Sabde, Yogesh Damodar, Saddik, Basema, Salamati, Payman, Salimi, Yahya, Salz, Inbal, Samy, Abdallah M, Sanabria, Juan, Sanchez Riera, Lidia, Santric Milicevic, Milena M, Satpathy, Maheswar, Sawhney, Monika, Sawyer, Susan M, Saxena, Sonia, Saylan, Mete, Schneider, Ione J C, Schwebel, David C, Seedat, Soraya, Sepanlou, Sadaf G, Shaikh, Masood Ali, Shams-Beyranvand, Mehran, Shamsizadeh, Morteza, Sharif-Alhoseini, Mahdi, Sheikh, Aziz, Shen, Jiabin, Shigematsu, Mika, Shiri, Rahman, Shiue, Ivy, Silva, João Pedro, Singh, Jasvinder A, Sinha, Dhirendra Narain, Soares Filho, Adauto Martins, Soriano, Joan B, Soshnikov, Sergey, Soyiri, Ireneous N, Starodubov, Vladimir I, Stein, Dan J, Stokes, Mark A, Sufiyan, Mu'awiyyah Babale, Sunshine, Jacob E, Sykes, Bryan L, Tabarés-Seisdedos, Rafael, Tabb, Karen M, Tehrani-Banihashemi, Arash, Tessema, Gizachew Assefa, Thakur, Jarnail Singh, Tran, Khanh Bao, Tran, Bach Xuan, Tudor Car, Lorainne, Uthman, Olalekan A, Uzochukwu, Benjamin S Chudi, Valdez, Pascual R, Varavikova, Elena, Vasconcelos, Ana Maria Nogales, Venketasubramanian, Narayanaswamy, Violante, Francesco S, Vlassov, Vasily, Waheed, Yasir, Wang, Yuan-Pang, Wijeratne, Tissa, Winkler, Andrea Sylvia, Yadav, Priyanka, Yano, Yuichiro, Yenesew, Muluken Azage, Yip, Paul, Yisma, Engida, Yonemoto, Naohiro, Younis, Mustafa Z, Yu, Chuanhua, Zafar, Shamsa, Zaidi, Zoubida, Zaman, Sojib Bin, Zamani, Mohammad, Zhao, Yong, Zodpey, Sanjay, Hay, Simon I, Lopez, Alan D, Mokdad, Ali H, Vos, Theo
    Publicado 2020
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Burden of injury along the development spectrum: associations between the Socio-demographic Index and disability-adjusted life year estimates from the Global Burden of Disease Study 2017
  7. 2667
    por Luu, Andrew
    Publicado 2016
    “…Thyroid eye disease (TED) is a condition mainly associated with Graves' disease. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Orbital radiotherapy for thyroid eye disease: case report with a review of the literature
  8. 2668
    “…To evaluate the efficacy of methotrexate for the treatment of thyroid eye disease (TED). Methods. 36 consecutive patients with active TED, previously treated with corticosteroids but stopped due to the occurrence of side effects, were commenced on methotrexate therapy. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Methotrexate for the Treatment of Thyroid Eye Disease
  9. 2669
    “…The superior efficiency of TEd for the insertion and deletion of long DNA fragments expands the applications of CRISPR for editing mammalian genomes.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Transcription-coupled donor DNA expression increases homologous recombination for efficient genome editing
  10. 2670
    “…Thyroid eye disease (TED), an autoimmune inflammatory disorder of the orbit, presents with a potential array of clinical sequelae. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Thyroid Eye Disease
  11. 2671
    “…CONTEXT: Inhibition of the neonatal fragment crystallizable receptor (FcRn) reduces pathogenic thyrotropin receptor antibodies (TSH-R-Ab) that drive pathology in thyroid eye disease (TED). OBJECTIVE: We report the first clinical studies of an FcRn inhibitor, batoclimab, in TED. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Proof-of-concept and Randomized, Placebo-controlled Trials of an FcRn Inhibitor, Batoclimab, for Thyroid Eye Disease
  12. 2672
    por Sayed, E, Yassen, KA
    Publicado 2016
    “…Transesophageal Doppler (TED), invasive mean arterial blood pressure (MAP) and heart rate (HR) were monitoring any Dex side effects and altering infusion rate accordingly; TED was used for fluid optimization. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Intraoperative effect of dexmedetomidine infusion during living donor liver transplantation: A randomized control trial
  13. 2673
    “…BACKGROUND: Very few studies have discussed transforaminal endoscopic discectomy (TED) in the treatment of common peroneal nerve paralysis induced by lumbar disk herniation (LDH). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Analysis of the clinical effects of transforaminal endoscopic discectomy on lumbar disk herniation combined with common peroneal nerve paralysis: a 2-year follow-up retrospective study on 32 patients
  14. 2674
    “…Asymptomatic TED elements such as subclinical hypothyroidism or IFG/IGT might become overt during pregnancy. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    New Entity—Thalassemic Endocrine Disease: Major Beta-Thalassemia and Endocrine Involvement
  15. 2675
    Publicado 1977
    “…Ted Wilson (left) and Rae Stiening…”
    Enlace del recurso
    At the SPS control room
  16. 2676
    “…In thyroid eye disease (TED), immunoglobulin G (IgG) autoantibodies target thyrotropin receptors (TSHR) on the thyroid gland causing Graves’ disease. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    ODP509 Proof-of-concept, Multicenter, Open-Label Phase 2a Study of Batoclimab in Active and Moderate-to-Severe Thyroid Eye Disease
  17. 2677
    “…SUBJECTS AND METHODS: Pediatric patients undergoing major abdominal surgery under general anesthesia with cardiac monitoring by transesophageal Doppler (TED) were included. Continuously recorded hemodynamic variables obtained from both bioreactance and TED were compared. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Comparison of monitoring performance of bioreactance versus esophageal Doppler in pediatric patients
  18. 2678
    “…BACKGROUND: Thyroid eye disease (TED) is a debilitating autoimmune orbital disease that is often a result of Graves’ disease. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Orbital radiotherapy plus three-wall orbital decompression in a patient with rare ocular manifestations of thyroid eye disease: case report
  19. 2679
    “…An important objective of examination of a patient with thyroid eye disease (TED) is determination of inflammation activity and severity. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Orbital decompression in the system of treatment for complicated thyroid eye disease: case report and literature review
  20. 2680
    “…PURPOSE: To describe the clinical features of thyroid eye disease (TED) in patients presenting at a tertiary eye care centre in North India and to identify factors predictive of severe disease. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Clinical profile of thyroid eye disease and factors predictive of disease severity
Herramientas de búsqueda: RSS